Changes in brain DHA concentration could affect lateral mobility collision rates between APP and secretases thus down-regulating APP processing and deposition of amyloid beta (Aβ) cleavage product into plaques, hallmarks of AD disease [8,31,35]. Here, APP is linked to Alzheimer disease.